ABSTRACT
A llergic rhinitis is defined as symptoms of sneezing, nasal itching, nasal obstruction, and watery rhinorrhea caused by immunoglobulin E (IgE) mediated inflammation against inhaled allergens. The diagnosis of allergic rhinitis is clinically based on concordance between a history of symptoms that correspond with exposure to the sensitizing allergen and diagnostic tests that indicate serum specific IgE (sIgE) values in serum or positive skin-prick test (SPT) results. 1 Allergen provocation tests are the most reliable tests but are limited in clinical practice due to a risk of adverse reactions. 2 House-dust mites (HDM) are the most common inhalant allergens in Korea. 3 However, the clinical correlation between exposure to a specific allergen and the development of nasal symptoms is rarely conclusive. For this reason, a test for the allergen sIgE value is usually used to determine the diagnosis of allergic rhinitis in daily practice. Although both SPT and serum sIgE tests have similar diagnostic properties, SPT is generally considered more accurate. 4 A previous study reported that SPT is more correlated with the nasal allergen provocation test than with blood testing for a diagnosis of inhalant allergy. 5 Historically, in vitro allergen test results have been dichotomously interpreted as positive or negative at a threshold of 0.35 kU/L of sIgE.
This level is primarily based on the technical limitations of firstgeneration sIgE assays. 6 Although levels of sIgE for allergens are divided into semiquantitative classes from class 0 (Ͻ0.35 IU/mL) to class VI (Ͼ100 IU/mL), a threshold of 0.35 kU/L of sIgE is commonly used without regard to allergen type or patient age group. Although there have been many comparative studies between SPT and the ImmunoCAP system (Thermo Fisher Scientific, Inc., Waltham, MA), to our knowledge, there have been no studies about the optimal cutoff value of sIgE based on the SPT as the clinical criterion standard. In this study, we hypothesized the following: (1) compared with the criterion standard of SPT, the cutoff value of sIgE differs among different inhalant allergens, and (2) this cutoff value changes according to age group. The aim of this study was to determine the cutoff value of sIgE in HDM and animal dander compared with SPT as the criterion standard.
METHODS

Study Subjects
Patients who visited our otorhinolaryngology-head and neck surgery department and presented with one or more rhinitis symptoms (nasal obstruction, nasal itching sense, sneezing, watery rhinorrhea) had both the SPT and the ImmunoCAP test. We excluded patients who did not have both tests or who underwent SPT and ImmunoCAP test on different days. A total of 16,209 patients were enrolled in this study between March 2008 and May 2014. This study protocol was approved by the institutional review board of Samsung Medical Center (SMC 2015-07-023), and the informed consent was waived. S.D. Hong and G. Ryu contributed equally to this work.
SPT and ImmunoCAP Test
Before performing the SPT, we screened patients for anaphylaxis and discontinued medications that interfere with test results, such as
antihistamines, antidepressants (amitriptyline, doxepin), antacid, and steroid ointment. SPTs were performed by following manufacturer's guidelines for Dermatophagoides pteronyssinus, Dermatophagoides farina, cat, and dog allergens. Allergen extracts (Allergy Therapeutics, Ltd., Bencard, England), along with the appropriate negative (0.9% saline solution) and positive (1 mg/mL histamine) controls, were applied on the upper back by using the prick technique. SPTs were evaluated 15 minutes after application and interpreted as the presence of sensitization when the wheal diameter was identical or larger than the size of histamine control wheal. A positive SPT result was defined as a wheal of Ͼ3 mm or an allergen-to-histamine ratio of Ն1. At the same time that the SPTs were performed, a blood sample was collected to quantify the sIgE levels by using the ImmunoCAP system.
Statistical Analysis
All statistical analyses were performed by using SAS 9.4 (SAS Institute, Cary, NC). Receiver operating characteristic curves were created to evaluate the predictive ability of D. pteronyssinus, D. farinae, cat, and dog sIgE levels in relationship to the criterion standard of the SPT results. The curve was constructed by using each unique value of the predictor variable as a possible cutoff point by calculating the corresponding sensitivity and specificity based on that cutoff point and then by plotting sensitivity versus 1 Ϫ specificity. By using receiver operating characteristic curve analysis, the optimal cutoff point was selected as the value that maximized the sum of sensitivity plus specificity, which is equivalent to using the Youden index. 7 Sensitivity and specificity were demonstrated for the selected cutoff point compared with traditional threshold values of 0.1, 0.35, 0.7, and 3.5. The Cochran-Armitage trend test was used to test positive rate trends among the age groups, and the Fisher exact test was used to test for gender difference. Absolute values of sIgE according to age group were analyzed by using analysis of variance with the post hoc Tukey test.
RESULTS
A total of 16,209 patients with allergic rhinitis symptoms were enrolled. The mean age was 31.8 years (range, 2-89 years), and male patients were predominant (male patients, 9374; females patients, 6835). The number of patients in each age group was as follows: Յ19 years, 5428; 20-29 years, 2865; 30-39 years, 2339; 40-49 years, 1931; 50-59 years, 2174; and Ն60 years, 1472. In summary, 10,103 patients were evaluated by using both the SPT and the ImmunoCAP test for D. pteronyssinus and D. farinae, 6517 patients were evaluated for cat sensitization, and 7495 patients were evaluated for dog sensitization. The results of the optimal cutoff value of sIgE selected by using the Youden index with the SPT as a criterion standard test are summarized in Table 1 . The cutoff values of sIgE for D. pteronyssinus, D. farinae, cat, and dog allergens were 0.69, 1.16, 0.13, and 0.45 kU/L, respectively. There was no significant difference in cutoff value according to gender (p Ͼ 0.05, Fisher exact test).
The sensitivity and specificity for each selected cutoff point to the traditional threshold values were 0.1, 0.35, 0.7, and 3.5 (Table 2) . At a cutoff point of 0.7 kU/L (class 2), the Youden index was maximal among the traditional threshold values for D. pteronyssinus and D. farinae. Conversely, the Youden index was maximum at 0.1 for cat and at 0.35 for dog allergens. Absolute values of the ImmunoCAP test showed a decreasing tendency for D. pteronyssinus and D. farinae with increased age (Fig. 1 A) . Absolute sIgE values were significantly different among the age groups except years 40s, 50s, and over 60 (p Ͻ 0.001 by using the analysis of variance test with the post hoc Tukey test). However, sIgE values for cat and dog allergens were not significantly changed with age, and the values were highest in the age of (Fig. 1 B) . When categorizing the age groups, cutoff values for D. pteronyssinus and D. farinae decreased with age (p Ͻ 0.05, Cochran-Armitage trend test). However, optimal cutoff values did not consistently decrease with age in cat and dog (Table 3) .
DISCUSSION
The present study found that the optimal cutoff values of sIgE for ImmunoCAP testing differed with the type of allergen and age group. The cutoff value for dog was approximately class I (0.45 IU/mL), whereas that for cat was lower than class I (0.13 IU/mL), and the cutoff value for HDMs was approximately class II (for D. pteronyssinus, 0.69; for D. farinae, 1.16 IU/mL). The sensitivity and specificity of immunoassays were previously reported as 60-95% and 30-95%, respectively. 4 A possible reason for this wide range is the difference in cutoff values according to allergen or age group. Gleeson et al. 8 demonstrated that ImmunoCAP sensitivity by using a cutoff value of 0.35 kU/L was 87% for HDM and 67% for cat. Specificity varied less among the different inhalant allergens (90-99%). In the present study, the maximum Youden index was verified only in dog, with the traditional threshold of sIgE at 0.35 IU/mL. The threshold with the maximum Youden index was Ͼ0.35 IU/mL in cat and higher in HDM. A recent study that compared ImmunoCAP and SPT results for 53 inhalant allergens showed diverse sensitivity and specificity according to allergen. Sensitivity and specificity for D. pteronyssinus was 69.4 and 90.7, for D. farinae was 75.7 and 91.6, for cat was 65.4 and 89.0, and for dog was 70.3 and 85.8, respectively. In that study, the single sIgE cutoff value was 0.35 IU/mL. 9 Although 65 to 91% accuracy demonstrates good concordance, sensitivity and specificity increased up to 90% for most allergens by using the new optimal cutoff values in the present study.
There could be some disagreement about our results because optimal cutoff values were deduced by using SPT as the criterion standard. The nasal provocation test would be a more suitable method for determining cutoff values; however, even these tests have limitations
Figure 1. Absolute values of serum-specific immunoglobulin E (IgE). (A) Absolute values of Dermatophagoides pteronyssinus and Dermatophagoides farinae had a tendency to decrease as age increased. (B)
The patients with positive skin-prick test results had higher serum-specific IgE levels than the general population, and positive rates decreased with age. 
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and are not practical in clinical settings. 10, 11 In a previous study, an allergy to HDM was confirmed by using the nasal provocation test in 70% patients with a positive SPT result. 12 Definite nasal symptom development after specific allergen exposure would be a better criterion standard than SPT, but there also are some drawbacks. Clinical correlation between exposure to a specific allergen and the development of nasal symptoms is very difficult to confirm. In addition, clinical symptoms of allergic rhinitis can change according to concurrent inflammation, infection, physical stress, psychological stress, exposure to irritants, and hormonal changes. 2 Nevertheless, our cutoff value of sIgE for cat allergen (0.13 IU/mL) was similar to the cutoff value of sIgE (0.12 IU/mL) of a previous study that analyzed symptom development after allergen exposure history. 6 Therefore, SPT is the second-best alternative as the criterion standard for allergen sensitization in patients with rhinitis. We showed that the cutoff value for sIgE differed according to age for D. pteronyssinus and D. farinae but not for cat and dog allergens. Even in the SPT positive result group, the absolute values of sIgE for D. pteronyssinus and D. farinae decreased with age. The difference of cutoff value of sIgE between HDMs and animals could derive from divergence of positive rates and exposure histories. The sensitization rate of animal dander is lower than that of HDM, and no data were available regarding real-life pet exposure histories, which was a limitation of the present study. Generally, allergy sensitization rates decrease with aging. In a Korean study, the frequency of sensitization to D. pteronyssinus, D. farinae, cat, and dog allergens when using SPT peaked in the age group 20-29 years and was lowest in the age group Ͼ60 years. 3 In the present study, the peak incidence of sensitization to D. pteronyssinus and D. farinae occurred in the age group 2-19 years and was at a minimum in the age group Ͼ60 years. The absolute values of D. pteronyssinus and D. farinae sIgE also peaked in the age group 2-19 years and were lowest in the age group Ͼ60 years.
Total and specific serum IgE levels have been shown to decrease with age in patients with allergic diseases. 13 In this study, the median absolute value of D. pteronyssinus and D. farinae sIgEs decreased with age. However, the optimal cutoff value calculated by the Youden index did not uniformly decrease with age. Allergen sensitivity confirmed by SPT usually decreased with age ( Fig. 1 B) . This lower sensitivity was explained by the altered quality of skin and subcutaneous tissue. However, the decreasing absolute number of sIgE values might be a more potent reason for lower sensitization in elderly patients (Fig. 1 A) . A decreasing sIgE level for D. pteronyssinus and D. farinae with age must be considered when interpreting SPT and ImmunoCAP tests. Many investigators indicate that SPT and serum sIgE testing cannot be used interchangeably. 9, [14] [15] [16] However, in some clinical conditions, such as extensive dermatitis, dermographism, or anaphylaxis, ImmunoCAP test must be used as an alternative to SPT. In such a situation, the sensitivity and specificity of ImmunoCAP tests can be up to 90% if clinicians use optimal cutoff values according to allergen type. Furthermore, clinicians must consider the tendency for a decreased sIgE titer with age when interpreting the results.
Positive SPT and ImmunoCAP results do not mean that a patient has an allergy to that allergen but only represent sensitization to an allergen. Because every enrolled patient had more than one allergic rhinitis symptom, positive SPT or ImmunoCAP test results were assumed to indicate the diagnosis of allergic rhinitis. Optimal cutoff values and sIgE consistently decreased for D. pteronyssinus, but the optimal cutoff value for D. farinae had a second peak in the age of 30 to 39. Optimal cutoff values differed by age group, and the values in Table 2 could be broadly applied to screen for allergic sensitization.
We recommend that optimal cutoff values should be chosen by considering the importance of higher sensitivity or specificity.
CONCLUSION
The optimal cutoff value for sIgE differed for each antigen and changed according to age. Physicians should select a proper cutoff value by using appropriate criteria according to the antigen and patient's age rather than by using a uniform cutoff value.
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